Cautious addition of targeted therapy to PD-1 inhibitors after initial progression of BRAF mutant metastatic melanoma on checkpoint inhibitor therapy.

Saved in:
Bibliographic Details
Title: Cautious addition of targeted therapy to PD-1 inhibitors after initial progression of BRAF mutant metastatic melanoma on checkpoint inhibitor therapy.
Authors: Samlowski, Wolfram1,2,3 (AUTHOR) wsamlowski1@gmail.com, Adajar, Camille2 (AUTHOR)
Source: BMC Cancer. 11/7/2021, Vol. 21 Issue 1, p1-12. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14712407
DOI:10.1186/s12885-021-08906-1